Resilience Care Expands to U.S. Market, Adds Veteran Digital Health Leaders

Leading Digital Oncology Solution Designed to Eliminate Clinical "Blind Spots" Through a Continuous Cancer Care Model

Mar. 31, 2026 at 9:51am

Got story updates? Submit your updates here. ›

Resilience Care, a digital oncology pioneer co-founded with Gustave Roussy Institute, announced its formal expansion into the United States. The company has appointed Greg Orr as General Manager, U.S. to lead this expansion. Orr brings deep expertise in scaling digital oncology support systems, most recently serving as Chief Operating Officer and Chief Commercial Officer of Jasper Health. Resilience Care has also assembled a powerhouse U.S. advisory board of digital health and oncology industry veterans to guide the company's market entry and growth.

Why it matters

Resilience Care's clinically validated platform aims to solve the industry's "between-visit blind spot" by providing a highly personalized digital patient experience that bridges the gap between clinic visits through real-time symptom tracking and adaptive treatment pathways. This proactive, data-driven approach has been shown to drive a 4-5x increase in nursing capacity and sustain an industry-leading 85% patient adherence rate even after a full year of use.

The details

Resilience Care's integrated platform provides timely patient symptom information to empower oncology teams to optimize their workflows while achieving a 92% clinician satisfaction rate. This symptom monitoring paradigm has been shown in peer-reviewed research to drive life-enhancing outcomes, including up to a 38% reduction in hospitalization and a 25% decrease in severe treatment-related toxicities. This continuous, data-driven support approach helps patients stay on their therapies longer - extending treatment duration by an average of 1.9 months.

  • Resilience Care announced its formal expansion into the United States on March 31, 2026.

The players

Resilience Care

A digital oncology company dedicated to eliminating the blind spot between clinic visits through a model of continuous cancer care. The company is co-founded with Gustave Roussy Institute, one of the world's top cancer centers.

Greg Orr

The newly appointed General Manager, U.S. for Resilience Care. Orr brings deep expertise in scaling digital oncology support systems, most recently serving as Chief Operating Officer and Chief Commercial Officer of Jasper Health.

Eddie Martucci, PhD

The President, U.S. for Resilience Care. Martucci is a biotech entrepreneur and co-founder of Akili Interactive, known for securing the first FDA authorization for a prescription digital therapeutic.

Jill DeSimone

An industry advisor for Resilience Care. DeSimone is the former President of U.S. Oncology at Merck and a recognized healthcare leader with deep expertise in commercializing breakthrough therapies.

Anne Ireland, DNP, RN, AOCN

The Chief Nursing Advisor for Resilience Care. Ireland is an accomplished oncology nurse executive and former Executive Director at City of Hope with extensive leadership experience at the Oncology Nursing Society.

Got photos? Submit your photos here. ›

What they’re saying

“Oncology care today is episodic - clinicians often only see patients periodically, but cancer toxicity evolves daily at home. Our goal is to help U.S. practices eliminate clinical blind spots and turn chaotic patient communication between visits into structured clinical triage. We are helping care teams see risk before it becomes an emergency.”

— Greg Orr, General Manager, U.S., Resilience Care

“There is substantial scientific evidence that digital tools can improve patient outcomes and satisfaction, including high-quality research published from Resilience Care.”

— Ethan Basch, MD, World-renowned Oncologist and Advisor to Resilience Care

“Capturing patient-reported symptoms in a structured way allows care teams to identify complications earlier and respond more effectively. Our goal is to integrate these capabilities into routine care in the US to support both patients and clinicians.”

— Charles Ferté, MD PhD, Chief Medical and Patient Experience Officer, Resilience Care

What’s next

Resilience Care plans to rapidly expand its presence in the U.S. market, leveraging its newly assembled advisory board and the expertise of General Manager Greg Orr to drive adoption of its clinically validated digital oncology platform among American healthcare providers.

The takeaway

Resilience Care's expansion into the U.S. market with its innovative digital oncology solution highlights the growing demand for technology-enabled tools that can help bridge the gap between clinic visits and empower care teams to proactively manage cancer patients' evolving needs and symptoms.